Form 4 Filing: Hexter Joshua Acquires (Grant) shares of $ORMP

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

ORAMED PHARMACEUTICALS INC.

Ticker: $ORMP

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-12

Shares: 599,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hexter Joshua, holds the title of COO & CBO at ORAMED PHARMACEUTICALS INC..

On 2026-11-12, the insider transacted 599,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Hexter Joshua (COO & CBO) was granted $0 of $ORMP

Post-Transaction Position: 1,685,130 shares

SEC Accession No: 0001213900-26-120034 (CIK: 1573235)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ORMP Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ORMP News Coverage